Search PDMR transactions

Notifier
Name of person with notification obligation
Frank Bringstrup
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Frank Bringstrup
Position
Deputy CEO/Deputy Managing Director
Initial notification
No
Amendment
Yes
Details of amendment
För 2. och 3. transaktion (av 4) är Plats för transaktionen korrigerat från "Utanför handelsplats" till "NASDAQ STOCKHOLM".
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Calliditas Therapeutics AB
Issuer´s LEI code
549300PVPZO8TNT76B58
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Calliditas Therapeutics AB SE0010441584 Acquisition 18,319 Quantity 0.00 SEK 01/07/2024 Outside a trading venue
Share Calliditas Therapeutics AB SE0010441584 Disposal 8,523 Quantity 205.56 SEK 01/07/2024 NASDAQ STOCKHOLM AB
Share Calliditas Therapeutics AB SE0010441584 Disposal 9,796 Quantity 205.49 SEK 02/07/2024 NASDAQ STOCKHOLM AB
Share Calliditas Therapeutics AB SE0010441584 Disposal 8,000 Quantity 205.80 SEK 03/07/2024 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Calliditas Therapeutics AB SE0010441584 Acquisition 01/07/2024 Outside a trading venue 18,319 (Quantity) 0.00 SEK
Calliditas Therapeutics AB SE0010441584 Disposal 01/07/2024 NASDAQ STOCKHOLM AB 8,523 (Quantity) 205.56 SEK
Calliditas Therapeutics AB SE0010441584 Disposal 02/07/2024 NASDAQ STOCKHOLM AB 9,796 (Quantity) 205.49 SEK
Calliditas Therapeutics AB SE0010441584 Disposal 03/07/2024 NASDAQ STOCKHOLM AB 8,000 (Quantity) 205.80 SEK
<< Back